Evaluating the optimal time for amikacin administration with respect to haemodialysis using an in vitro pharmacodynamic simulation against epidemic nosocomial OXA-48 producing Klebsiella pneumoniae ST405 strains-Reference-Cited by-同舟云学术

Evaluating the optimal time for amikacin administration with respect to haemodialysis using an in vitro pharmacodynamic simulation against epidemic nosocomial OXA-48 producing Klebsiella pneumoniae ST405 strains

Published:2019-12 Issue: Volume:19 Page:241-251
ISSN:2213-7165
Container-title:Journal of Global Antimicrobial Resistance
language:en
Short-container-title:Journal of Global Antimicrobial Resistance

Author:

Carcas Antonio J.,Sevillano David,González Natalia,Alou Luis,Gómez-Gil Rosa,Muñoz Mario,Llanos Lucia,Sanchez-Villanueva Rafael J.,Gonzalez-Parra Emilio,Giménez Maria-Jose,Aguilar Lorenzo

Funder

Instituto de Salud Carlos III

Ministerio de Ciencia y Tecnología

I+D+I

FEDER

Publisher

Elsevier BV

Subject

Microbiology (medical),Immunology,Immunology and Allergy,Microbiology

Reference46 articles.

1. Infections caused by OXA-48-producing Klebsiella pneumoniae in a tertiary hospital in Spain in the setting of a prolonged, hospital-wide outbreak;Paño-Pardo;J Antimicrob Chemother,2013

2. Genome sequence of OXA-48 carbapenemase-producing Klebsiella pneumoniae KpO3210;Wesselink;J Bacteriol,2012